These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 2256508)
1. Short-term effects of smoking on the pharmacokinetic profiles of micronized estradiol in postmenopausal women. Cassidenti DL; Vijod AG; Vijod MA; Stanczyk FZ; Lobo RA Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1953-60. PubMed ID: 2256508 [TBL] [Abstract][Full Text] [Related]
2. Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy. Jensen J; Christiansen C Am J Obstet Gynecol; 1988 Oct; 159(4):820-5. PubMed ID: 2972209 [TBL] [Abstract][Full Text] [Related]
4. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. Jensen J; Christiansen C; Rødbro P N Engl J Med; 1985 Oct; 313(16):973-5. PubMed ID: 4047104 [TBL] [Abstract][Full Text] [Related]
5. Acute and long-term estradiol kinetics in smoking postmenopausal women. Bjarnason NH; Jørgensen HL; Christiansen C Climacteric; 2012 Oct; 15(5):449-54. PubMed ID: 22191426 [TBL] [Abstract][Full Text] [Related]
6. Androgen and estrogen dynamics in pre- and postmenopausal women: a comparison between smokers and nonsmokers. Longcope C; Johnston CC J Clin Endocrinol Metab; 1988 Aug; 67(2):379-83. PubMed ID: 3392163 [TBL] [Abstract][Full Text] [Related]
7. Serum estradiol-binding profiles in postmenopausal women undergoing three common estrogen replacement therapies: associations with sex hormone-binding globulin, estradiol, and estrone levels. Nachtigall LE; Raju U; Banerjee S; Wan L; Levitz M Menopause; 2000; 7(4):243-50. PubMed ID: 10914617 [TBL] [Abstract][Full Text] [Related]
8. A reevaluation of estrogen status in postmenopausal women who smoke. Cassidenti DL; Pike MC; Vijod AG; Stanczyk FZ; Lobo RA Am J Obstet Gynecol; 1992 May; 166(5):1444-8. PubMed ID: 1534446 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of a new conjugated oral estrogen, estradiol-3beta-glucoside, with oral micronized 17beta-estradiol in postmenopausal women. Sweeney AT; Tangpricha V; Weinberg J; Malabanan AO; Chimeh FN; Holick MF Transl Res; 2006 Oct; 148(4):164-70. PubMed ID: 17002918 [TBL] [Abstract][Full Text] [Related]
11. Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure. Steingold KA; Matt DW; DeZiegler D; Sealey JE; Fratkin M; Reznikov S J Clin Endocrinol Metab; 1991 Aug; 73(2):275-80. PubMed ID: 1906893 [TBL] [Abstract][Full Text] [Related]
12. Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease. Reed MJ; Cheng RW; Noel CT; Dudley HA; James VH Cancer Res; 1983 Aug; 43(8):3940-3. PubMed ID: 6683128 [TBL] [Abstract][Full Text] [Related]
13. Different hepatobiliary effects of oral and transdermal estradiol in postmenopausal women. Van Erpecum KJ; Van Berge Henegouwen GP; Verschoor L; Stoelwinder B; Willekens FL Gastroenterology; 1991 Feb; 100(2):482-8. PubMed ID: 1898652 [TBL] [Abstract][Full Text] [Related]
14. [Transdermal and oral hormone substitution with estrogens: a comparison]. Schindler AE Zentralbl Gynakol; 1995; 117(10):504-7. PubMed ID: 7491831 [TBL] [Abstract][Full Text] [Related]
15. Comparison of pharmacodynamic properties of various estrogen formulations. Mashchak CA; Lobo RA; Dozono-Takano R; Eggena P; Nakamura RM; Brenner PF; Mishell DR Am J Obstet Gynecol; 1982 Nov; 144(5):511-8. PubMed ID: 6291391 [TBL] [Abstract][Full Text] [Related]